Mark David Hackett

Current roles
1
Investments attributed
3
Board seats
2
Form D directors and board-seat deals
As of · this person's identity; each section below carries its own date

What matters now

  1. 2020
    since

    Manager at Solas Bioventures Management, LLC since 1 Mar 2020.

    Tenure says how settled this partner is at the firm.

    FactForm ADV Schedule A and the firm's team pageFor Founders, LPsRoles →
Drawing the relationship network…

Roles

1 current, 0 past

Investments attributed to this person

3
CompanyRoundInvestorAttributionDateSource
CardioNXTForm D equity offering · $3.0MSolas Bioventures Management, LLCstrongly supported · boardMar 27, 2019Inference sec.gov
Glenveigh Pharmaceuticals, LLCForm D equity offering · $1.1MSolas Bioventures Management, LLCstrongly supported · boardMay 14, 2012Inference sec.gov
Glenveigh Pharmaceuticals, LLCForm D equity offering · $250,000Solas Bioventures Management, LLCstrongly supported · boardNov 29, 2011Inference sec.gov

Board seats and vehicles

2 boards, 0 vehicles

Timeline

4 dated entries: events, attributed deals, board seats and role changes
  1. Mar 1, 2020
    Joined Solas Bioventures Management, LLC as Manager
  2. Mar 27, 2019
    Form D equity offering in CardioNXT (Solas Bioventures Management, LLC)
    Attributed investment Inference CardioNXT Form D
  3. May 14, 2012
    Form D equity offering in Glenveigh Pharmaceuticals, LLC (Solas Bioventures Management, LLC)
    Attributed investment Inference Glenveigh Pharmaceuticals, LLC Form D
  4. Nov 29, 2011
    Form D equity offering in Glenveigh Pharmaceuticals, LLC (Solas Bioventures Management, LLC)
    Attributed investment Inference Glenveigh Pharmaceuticals, LLC Form D